17:49 - 6.01.2023
January 6, Fineko/abc.az. The Azerbaijani representative office of the Danish pharmaceutical manufacturer Novo Nordisk A/S appealed to health workers and the population.
ABC.AZ reports that the application submitted to the Public Relations & Communication Department of the Analytical Expertise Center states that due to the high demand for the Ozempik® drug, numerous counterfeit Ozempik® 0.5 mg and 1.0 mg medicines are observed in the market. The representative said that all cases of counterfeiting are monitored and recorded by Novo Nordisk.
Currently, counterfeiting cases have been registered in Kazakhstan, Russia, Azerbaijan, and Uzbekistan.
26 April 2024
25 April 2024
25 April 2024
25 April 2024
25 April 2024
25 April 2024
25 April 2024
25 April 2024
25 April 2024
25 April 2024
25 April 2024
25 April 2024
25 April 2024
25 April 2024
25 April 2024
25 April 2024
25 April 2024
24 April 2024
24 April 2024
24 April 2024
24 April 2024
24 April 2024
25 April 2024
23 April 2024
23 April 2024
24 April 2024